FDA OKs KV Pharmas Generic Tiazac
[ Price : $8.95]
FDA approves a KV Pharmaceutical Co. ANDA for a generic copy of Forest Pharmaceuticals calcium channel blocker Tiazac in six dosag...
Graham Criticizes Mercks Development of Arcoxia
[ Price : $8.95]
In a just-posted JAMA editorial, FDA whistleblower David Graham questions Mercks decision to pursue approval of its next generatio...
